The process of determining ADI involves rigorous scientific assessment, generally starting with animal testing to identify the No-Observed-Adverse-Effect Level (NOAEL). The NOAEL is the highest exposure level at which there are no significant adverse effects observed. To account for variability between species and individual sensitivities, a safety factor (often 100) is applied to the NOAEL to derive the ADI.